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Does SNOT-22 Score Predict OSA
Incidence?
Patrick Zhu, Chandala Chitguppi, Mindy Rabinowitz, MD*
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Introduction
Problem:
- Pt w/ chronic rhinosinusitis want/need surgery (ESS)
- Comorbid OSA
- Higher risk of perioperative complications
- Less probability of achieving QoL improvement
- Underdiagnosed and often undiagnosed
- Requires a sleep study (expensive) for diagnosis
- It is unclear who benefits from screening

Introduction
• STOP-BANG – widely accepted OSA screening tool
– Not universal in the setting endoscopic sinus surgery (FESS)

• SNOT-22 - a standard survey for endoscopic sinus surgery
patients (given pre/post ESS)
– Surveys outcomes for several domains of quality of life
– Rhinologic, extranasal rhinologic, ear/facial, psych dysfxn sleep dyfxn

• Can SNOT-22 be used as a screening tool?
–
–
–
–

Specifically, the sleep domain?
Would be good triage tool for sleep-study
OSA screening can be done w/ minimal practice change
Retrospective studies can be done to assess community risk

Objectives
& Hypothesis
• Q: Can SD-SNOT-22 score predict OSA
incidence in patients with chronic
rhinosinusitis following surgery?
• H: High SD-SNOT score is positively predictive
of OSA incidence of OSA in CRS patients
following surgery 3 months postoperatively.

Approach & Results
• Retrospective chart review of 200-300 patients from 11/2019 –
1/2020
– Data source: TJUH ENT patients, from database of ESS patients

• Split into 2 groups – Dx'd OSA & non-OSA – compared SNOT-22
score / STOP-BANG (if present)
– Obtain sleep domain of SNOT-22 scores of pre-ESS and 3mo post-ESS
SNOT score

• Compare post-op CRS patient with vs without OSA diagnosis
(control)
– Is there a range/cutoff sleep domain score that is significantly
associated w/ OSA diagnosis?

Approach & Results
• Analysis
– SD-SNOT was higher in OSA group preoperatively
• 22.4±12.9 vs. 14.7±11.4; p=0.02

– SD-SNOT was higher in OSA group postoperatively
•

20.8±15.0 vs. 6.8±8.6; p=0.02

- STOP-BANG was NOT significantly higher in OSA group,
preoperatively
– STOP-BANG was significantly higher OSA group, postoperatively
• 6.5±0.7 vs. 1.8±0.7; p=0.02

- Further analysis of STOP-BANG not performed due to lack of
administration (n=17)

Approach & Results
• Calculated SD-SNOT-22 cutoffs for OSA
– Fischer-exact chi square
• Preoperative – 21 (OR:3.5; CI:1.1-10.7; p=0.02)
• Postoperative – 16 (OR 10.5; CI;1.3-83.5; p=0.03)
Tested association of OSA diagnosis with SD score pre-op
SD Score

P Value

Odds Ratio

95% CI

Less than 19 vs.
More than 19

0.06

Less than 20 vs.
More than 20

0.04*

3.5

1.1-10.7

Less than 21 vs.
More than 21

0.02

8.75

1.3-58.8

Approach and Results
• Group comparison 2 mo post-ESS (Kruskal Wallis)
Variable

Non-OSA

OSA

P value

Age

48.44 ± 18.19

57.2 ± 9.49

0.04*

BMI

27.33±6.21

40.71±40.69

<0.0001*

Total SNOT score at
3m

20.82±19.94

38.33±24.5

0.06

Rhinologic domain
at 3m

10.56±8.46

11.83±9.6

0.78

Facial domain at 3m 2.67±3.93

3.33±2.73

0.17

Sleep domain at 3m 7.05±8.83

20.50±14.09

0.007*

Psychological
domain at 3m

0.55±1.48

2.67±3.07

0.13

STOP-BANG score

2.00±1.2

4.33±2.01

0.001*

Approach & Results
QoL improvement comparison between groups
• Delta SNOT score, post-ESS 3 mo (Kruskal Wallis)
Total SNOT

Facial
domain

Sleep
domain

Psychologic
al domain

Non-OSA
10.52±15.27 3.91±7.54
(Mean ± SD)

1.41±3.28

4.72±8.22

0.45±1.91

OSA
11.33±15.87 4.66±7.20
(Mean ± SD)

3.83±2.63

1.5±7.68

1.33±1.96

P value

0.04*

0.22

0.36

0.82

Rhinologic
domain

0.85

Approach & Results
OSA Screening characteristics for score
21 or greater
•
•
•
•

Sensitivity: 50%
Specificity: 89.7%
PPV: 42.9%
NPV: 92.1%

Conclusions
• SD-SNOT-22 of 21 pre-operatively and 16 postoperatively indicates underlying OSA
• Likely better as a rule-out tool
– Similar to STOP-BANG practically speaking

• No other study documents SNOT-22 use for
this purpose
• Underdiagnosis itself was a limitation
• Utility: improved screening with zero change
to perioperative procedure

Future Directions
• Retroactive application of the test to address
potential underdiagnosis in populations
• Incorporate of screening into perioperative
care, universally
• Replication in a “less underdiagnosed”
population?
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